Two-Year Cohort Study of SARS-CoV-2, Verona, Italy, 2020‒2022

We performed a follow-up of a previously reported SARS-CoV-2 prevalence study (April‒May 2020) in Verona, Italy. Through May 2022, only <1.1% of the city population had never been infected or vaccinated; 8.8% was the officially reported percentage. Limiting protection measures and vaccination boo...

Descripción completa

Detalles Bibliográficos
Autores principales: Bisoffi, Zeno, De Santis, Nicoletta, Piubelli, Chiara, Deiana, Michela, Perandin, Francesca, Girardi, Pietro, Heller, Luca, Alba, Natalia, Pomari, Carlo, Guerriero, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2023
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045681/
https://www.ncbi.nlm.nih.gov/pubmed/36918375
http://dx.doi.org/10.3201/eid2904.221268
Descripción
Sumario:We performed a follow-up of a previously reported SARS-CoV-2 prevalence study (April‒May 2020) in Verona, Italy. Through May 2022, only <1.1% of the city population had never been infected or vaccinated; 8.8% was the officially reported percentage. Limiting protection measures and vaccination boosters to elderly and frail persons seems justified.

Ejemplares similares